The production of 20-Hydroxyeicosatetraenoic acid (20-HETE) in the kidney is thought to be involved in the control of renal vascular tone and tubular sodium and chloride reabsorption. 20-HETE production in the kidney has been extensively studied in rats and humans and occurs primarily via the actions of P450 enzymes of the CYP4A and 4F families. Recent advancements in molecular genetics of the mouse have made it possible to disrupt genes in a cell-type specific fashion. These advances could help in the creation of models which could distinguish between the vascular and tubular actions of 20-HETE. However, isoforms of the CYP4A and 4F families which may be responsible for the production of 20-HETE in the vascular and tubular segments in the kidney of the mouse are currently unknown. The goal of this study was to identify the isoforms of the CYP4A and 4F family along the nephron by rt-PCR of RNA isolated from microdissected renal blood vessels and nephron segments from 16-24 week old male and female C57BL/6J mice. CYP4A and 4F isoforms were detected in every segment analyzed with sex differences only observed in the proximal tubule and glomeruli. In the proximal tubule segments from male mice, the 4A10 and 12 isoforms were present, while the 4A10 and 14 isoforms were detected in segments from female mice. In glomeruli, sex differences in the expression pattern of CYP4F isoforms were also observed with male mice expressing the 4F13, 14 and 15 isoforms, whereas, female mice expressed the 4F13, 16 and 18 isoforms. These results demonstrate that isolated nephron and renal vessel segments express multiple isoforms of the CYP4A and 4F families, therefore, elimination of a single CYP4A or 4F isoform may not decrease 20-HETE production in all nephron segments or the renal vasculature of male and female mice. However, the importance of CYP4A versus 4F isoforms to the production of 20-HETE in each of these renal tubular and vascular segments of the mouse remains to be determined. Stec, et al.
Introduction

20-Hydroxyeicosatetraenoic acid (20-HETE) is the major metabolite of arachidonic acid
produced in the kidney of several species including humans (22) . 20 -HETE has been reported to regulate renal vascular tone (12, 30) , mediate tubuloglomerular feedback (31), and inhibit electrolyte transport in several nephron segments (6, 20) . Alterations in renal 20-HETE production may also contribute to the development of hypertension in both the spontaneously hypertensive rat (SHR) and Dahl salt-sensitive (Dahl S) rat (21, 24, 25) .
Three isoforms of the CYP4A family have been cloned in the mouse and include the CYP4A10, CYP4A12, and CYP4A14 isoforms. Bell et al. (2) identified the CYP4A12 as the primary isoform that is constitutively expressed in the kidney of male and female mice with the levels in male being much higher than those in the female. The CYP4A10 and CYP4A14 isoforms are expressed at lower levels in the mouse kidney under basal conditions; however, both isoforms were markedly inducible by treatment with the peroxisome proliferator, methylclofenapate (2, 8) .
Although the mouse CYP4A isoforms share a high degree of amino acid identity with the rat CYP4A isoforms (7) , the catalytic activity of the mouse CYP4A10 and CYP4A12 isoforms in regard to the production of 20-HETE has yet to be determined. In human kidney, the only isoform of the CYP4A family to be cloned is the CYP4A11 (2) . However, in contrast to the rat, recent studies have indicated that the primary isoforms responsible for the production of 20-HETE in the human kidney are members of the CYP4F family (4, 16) .
In the mouse, five members of the CYP4F family have also been identified. The CYP4F15 and the CYP4F16 isoform being the more abundant transcript (5) . In the kidney, the CYP4F15 isoform is highly inducible by clofibrate, while clofibrate has no effect on the levels of CYP4F16 levels (5) . Sex differences in the levels of CYP4F expression in the kidney have yet to be reported. Although CYP4F isoforms in the human kidney have been demonstrated to produce 20-HETE (4, 16) , the ability of the CYP4F isoforms expressed in the kidney of mice and rats to metabolize AA and produced has not yet been demonstrated.
The dissection of complex paracrine systems has been successfully accomplished by either targeted overexpression or disruption of specific genes in transgenic and gene knockout mice.
Advances in mouse genetics allow for targeted overexpression and deletion of genes in specific nephron segments of the kidney (17, 26) . The development of these approaches would greatly increase our understanding of the physiologic consequence of altered renal tubular or vascular 20-HETE production. Targeted disruption of the CYP4A14 gene has been described (10); however, instead of decreasing renal 20-HETE production, loss of this isoform was associated with increased production of 20-HETE in the kidney and hypertension in male mice. The increased 20-HETE production in these mice was attributed to an increase in the expression of the CYP4A12 isoform, however, changes in the expression of CYP4F isoforms was not considered in this previous study (10) . The results from this study indicate that 20-HETE produced in the kidney of the mouse may be derived from multiple isoforms of the CYP4A and CYP4F families in a sex and cell-type specific fashion. In the present study, we set out to identify the isoforms of the CYP4A and CYP4F family present in specific nephron segments and renal vessels of the mouse. This was accomplished by designing specific primers to amplify the individual isoforms of the CYP4A and CYP4F families and performing rt-PCR on bulk-isolated nephron segments and renal microvessels from both male and female mice.
Methods
Animals. Studies were performed on 16-24 week male and female C57BL/6J mice purchased from Jackson Labs (Bar Harbor, ME). All mice were housed under standard conditions and allowed full access to food and water. All procedures were approved by the Institutional Animal were collected under a stereomicroscope and placed in 100 µL of lysis buffer for a rt-PCR specific RNA isolation kit (RNAqueous, Ambion, Austin, TX).
TALH were isolated from the outer medulla of the kidney after enzymatic digestion and the supernatant was collected and placed on a 70-µm nylon sieve. The sieve was rinsed several times with ice-cold digestion solution and the retained tissue was washed off the sieve with wash solution containing 1% BSA. Individual TALH segments were the collected under a stereomicroscope with fine forceps and placed into the lysis solution for RNA isolation.
Collecting ducts were isolated from 1 mm thick coronal sections of the whole kidney after 1 hour incubation in digestion solution at 37 o C for 1 hour while O 2 was continuously blown over the mix. After the digestion period, both cortical and medullary collecting ducts were collected under a stereomicroscope with fine forceps and placed into the lysis solution for RNA isolation.
Isolation of renal microvessels and glomeruli. Renal vessels were isolated from the kidney using a modified Evans blue technique (13) . Briefly, the kidney was flushed with 3 mls of wash solution followed by another 3 mls of wash solution containing 1% (wt:vol) Evans blue (Sigma Chemical, St. Louis, MO). The kidneys were then hemisected and forced through a 180 µm nylon sieve. The remaining tissue was rinsed several times with wash solution containing 1% BSA. The tissue was then collected from the sieve and lightly homogenized several times with a Polytron homogenizer. The resulting suspension was then passed several times through a 20 G needle followed by a 22 G needle. The suspension was then passed though a 180 µm mesh sieve that was on top of a 100 µm mesh sieve. After several washes with 1% BSA in wash solution, the material retained by each of the sieves was collected. Each microvascular fraction was examined under a stereomicroscope and most vessel segments were found to be totally void of glomeruli and tubules. Clean vessels segments were then collected using fine forceps and placed into the lysis solution for RNA isolation. Glomeruli were isolated by a rapid sieving technique as previously described (23) . The material passing through the 180 µm sieve after the kidney was forced through was collected, passed though a 100 µm sieve and onto a 70 µm sieve. The 70 µm sieve was rinsed several times with 1% BSA in wash solution and the material collected.
The fraction was then examined under a stereomicroscope and individual glomeruli devoid of visible tubular contamination were collected (100 total) and place into lysis solution for RNA isolation.
RNA isolation and rt-PCR.
RNA was isolated using a commercially available kit specifically designed for rt-PCR according to manufactures' guidelines (RNAqueous, Ambion, Austin, TX).
RNA was eluted in a 60 µl volume with nuclease-free water. 10 µl of RNA was then used in a reverse transcription reaction using an oligo-dT primer with AMV reverse transcriptase in a 20 µl final volume. In order to control for amplification of genomic DNA, reactions lacking AMV reverse transcriptase were run in parallel. PCR was performed on 1 µl of the reverse transcription reaction in a 25 µl volume using standard PCR reaction conditions. The PCR reactions for the CYP4A isoforms were cycled as follows: Experiments were repeated on 4 individual male and female mice. Gels were visualized under ultraviolet illumination and images captured using a gel documentation system with software supplied by the manufacturer (Gel Doc 2000, Bio-Rad, Hercules, CA). PCR products from all isoforms amplified from either whole kidney or liver were cloned into TA cloning vectors (Invitrogen, Carlsbad, CA). Two independent clones for each isoform were then sequenced in order to confirm specificity of PCR primers. µM) in an NADPH-regenerating system as previously described(24). Additional experiments were then performed comparing the ability of microsomes prepared from the kidneys of male and female rats to metabolize AA using a lower concentration of AA (1 uCi; 1.8 uM) because the percent conversion of AA to 20-HETE in renal microsomes of C57/Bl6 was found to be very low relative to rats, rabbits and other species previously reported (1). The reactions were terminated by the acidification with formic acid and extracted twice with ethyl acetate and dried under N 2 gas. The metabolites were then resuspended in 500 µL of 100% ethanol. The metabolites were separated by HPLC using a C18 reverse-phase column (2.1 X 250 mm, 5 µm; 
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Results
Expression of Cyp4A isoforms in nephron segments and renal vessels.
In the proximal tubule, the CYP4A10 and CYP4A12 isoforms were the only isoforms detected in male mice ( Figure   1A ). This was in contrast to female mice in which the CYP4A10 and CYP4A14 isoforms were detected in the proximal tubule ( Figure 1B) . The CYP4A12 isoform could not be amplified from proximal tubules isolated from female mice. The CYP4A10 isoform was the only isoform that could be amplified from the TALH and collecting ducts of both male and female mice (Figures 2   and 3 ). In the renal vessels, the CYP4A10 isoform was the only isoform that could be detected in both large (>180 µm diameter) and small (between 180 and 100 µm diameter) vessels ( Figure   4 ). There were no sex differences in the expression pattern of CYP4A isoforms in the renal vasculature (Figures 4 and 5) . The CYP4A10 isoform was also the only isoform expressed in isolated glomeruli from both male and female mice ( Figure 6 ).
Expression of Cyp4F isoforms in nephron segments and renal vessels. Proximal tubule segments
from both male and female mice exhibited identical patterns of expression of CYP4F isoforms.
The CYP4F13, CYP4F14, CYP4F16 and CYP4F18 isoforms were all detected in proximal tubule segments from both sexes ( Figure 1A and B) . In the TALH and collecting duct, the CYP4F13 and CYP4F16 isoforms were detected in both male and female mice (Figures 2 and   3 ). In the renal vasculature, the CYP4F13, CYP4F16 and CYP4F18 isoforms were all detected in large vessels in both male and female mice (Figure 4) . However, the CYP4F13 isoform was the only isoform amplified from small vessel segments in both sexes ( Figure 5 ). Sex differences in the expression pattern of CYP4F isoforms were also apparent in glomeruli. In glomeruli from male mice the CYP4F13, CYP4F14 and CYP415 isoforms were detected ( Figure 6A) ; whereas, the CYP4F13, CYP4F16 and CYP4F18 isoforms were detected in glomeruli from female mice ( Figure 6B ). The expression pattern of the CYP4A and CYP4F isoforms between male and female mice is summarized in Figure 7 .
AA metabolism. We first characterized the renal metabolism of AA in the kidney and liver of male C57/BL6 mice using the same substrate concentration (42 uM) and incubation time (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) min) previously used in rats (1) . The results of these experiments are present in Table 1 .
Microsomes prepared from the liver of these mice avidly produced 20-HETE, 14,15-, 11,12-, The overall production rate of 20-HETE was similar to the levels previously reported in rat liver microsomes (14) . Mouse renal cortical microsomes produced primarily 20-HETE with lesser quantities of EETs, and DiHETEs and largely 15-and 12-HETEs. However, the catalytic activity of the microsomes to produce 20-HETE and EETs was about 5 times lower than that seen in the liver of these same mice or in comparison to the levels previously observed in renal cortical microsomes of the rat (1, 14) . We tried a number of different substrate concentrations, cofactor additions, incubation times, different amounts of protein (0.25-2 mg) in the reactions but could not increase conversion rates.
Because of the low conversion rates of AA to EETs and 20-HETE, we therefore choose to compare the relative activity of microsomes prepared from the kidneys of male and female rats using only 14-C AA (1.8 uM) to maximize the conversion rates and our ability to detect differences in activity. The production of 20-HETE was lower in microsomes prepared from the renal cortex of female mice as compared to male mice (1.38 + 0.13, vs. 1.71 + 0.12 pmoles/min/mg protein), however; this difference did not reach statistical significance ( Table 2 ).
The production of 20-HETE, in the outer medulla of male and female mice was not statistically (Table 2) .
Discussion
The goal of the present study was to examine the distribution of CYP4A and CYP4F isoforms along the nephron and in renal micovessels of C57BL/6J mice in order to determine what 20-HETE producing enzymes may be present in these tubular and vascular segments. This information is especially useful in the context of defining an experimental approach to reduce the production of 20-HETE in one of these segments by elimination of a CYP4A or CYP4F isoform.
Although the CYP4A10 and CYP4F13 isoforms were detected in every tubular and vascular segment examined, some segments also express other CYP4A and CYP4F isoforms which may be able to produce 20-HETE if the CYP4A10 or CYP4F13 isoforms were inactivated by gene targeting. For example, in the TALH of mice the CYP4A10 isoform is present as well as two isoforms of the CYP4F family. Elimination of this CYP4A isoform would leave the other CYP4F isoforms still intact, which might be sufficient to produce 20-HETE in this nephron segment. Previous studies have demonstrated that 20-HETE is a regulator of chloride transport in the TALH (6) and that decreased production of 20-HETE in the TALH may be responsible for the shifting of the pressure-naturetic response and the development of hypertension in Dahl S rats (15) . However, this hypothesis may be difficult to test in mice in which the CYP4A10 isoform has been deleted in the TALH since this nephron segment expresses multiple CYP4F
isoforms. Likewise, 20-HETE has been demonstrated to be a potent vasoconstrictor of the renal microcirculation (12) and alteration in the production of 20-HETE in renal arterioles is thought to contribute to the development of hypertension in the SHR (25, 29). Even though the CYP4A10 isoform was the only isoform detected in renal blood vessels of male and female mice, disruption of this isoform may not lead to a decrease in 20-HETE production in renal blood vessels due to the presence of the CYP4F13 isoform in small vessels and multiple CYP4F
isoforms in large vessels.
In the present study we observed numerous sex differences in distribution of CYP4A and CYP4F isoforms in different tubular and vascular segments. In the proximal tubule, male mice expressed the CYP4A10 and CYP4A12 isforms, while the CYP4A10 and CYP4A14 isoforms were detected in females. The expression of the CYP4A14 isoform but not the CYP4A12 isoform in female mice under basal conditions is in agreement with previous studies using
Northern blot analysis of whole kidney RNA (10) . However, castration of male mice leads to marked increase in the levels of the CYP4A14 and decrease in the CYP4A12 isoform in the kidney suggesting a role for testosterone as a negative and positive regulator of these genes in mice. Both of these changes in expression can be prevented by treatment of mice with dihydrotestosterone (DHT) (10) . Interestingly, renal 20-HETE production is correlated with changes in the expression of the CYP4A12 isoform following castration and DHT treatment (10) , suggesting that this isoform may be responsible for the higher rate of 20-HETE production in the renal cortex of male versus female mice. Previous studies have also detected increased levels of lauric acid hydroxylase activity and CYP4A protein in the kidney of male versus female mice (9).
The only sex difference in distribution of the CYP4F isoforms was found in the glomerulus.
Glomeruli from male mice expressed the CYP4F13, CYP4F14 and CYP4F15 isoforms, while female mice expressed the CYP4F13, CYP4F16 and CYP4F18 isoforms. Expression of the CYP4F15 isoform in the glomeruli of male mice was the only segment in which the CYP4F15 isoform was detected in the present study. Interestingly, this isoform could not be amplified from whole kidney RNA samples but could be readily amplified from the liver (unpublished observation). If the CYP4F15 isoform avidly metabolizes AA to 20-HETE, the differential expression of CYP4F15 in the liver versus the kidney may contribute to the present observation that the production of 20-HETE is much greater in the liver versus the kidney of C57BL/6J mice.
This concept is consistent with the results of recent studies indicating that the CYP4F2 is the primary isoform responsible for the production of 20-HETE in the kidney of humans (4, 16), whereas, other human isoforms such as the CYP4F8 and CYP4F12 isoforms appear to primarily metabolize prostaglandins and leukotrines (3, 19) . The murine CYP4F14, 4F15, 4F16, and 4F18 isoforms share a high degree of amino acid homology with the CYP4F2 isoform (Table 3) .
Of these, the CYP4F16 isoform was the isoform that was detected in most vascular and tubular segments analyzed. However, at the present time the relative catalytic activity of the murine CYP4F isoforms to metabolize AA versus other substrates is unknown, so it is difficult to speculate on which isoform is most important in producing 20-HETE in various tubular and vascular segments of the murine kidney.
In order to determine the functional significance of the observed differences in CYP 4A and 4F isoform distribution in male and female C57BL/6J mice, we measured the metabolism of AA by microsomes prepared from the cortex and outer medulla of the kidney. Despite the fact that we characterized clear sex differences in the expression of CYP 4A and 4F mRNA in various nephron segments of the kidney, we did not detect any significant difference in the production of 20-HETE by microsomes prepared from the renal cortex or outer medulla of male and female C57BL/6J mice. The reason for this observation remains to be determined but there are many possible explanations. For example, the CYP4A and CYP4F proteins in the kidney may be different that the isoforms detected by rt-PCR in the present study. It is also possible that many of the murine isoforms do not metabolize AA to 20-HETE but are primarily involved in the hydroxylation of prostaglandings and leukotrienes in vivo.
Interestingly, we found that the production of 20-HETE was much lower in the kidney of mice in comparison to that reported in other species and about 5 times lower than that seen in the liver of the same animal (1, 14) . The low level of 20-HETE production in the kidney of C57BL/6J female mice is in agreement with previous reports of wild-type CYP4A14 knockout mice on a 129 mixed genetic background (10) . Previous reports of renal 20-HETE production in male mice have indicated higher levels in both a mixed 129 genetic background (10) as well as in NMRI mice (11) . Since we only examined distribution of CYP 4A and 4F isoforms in C57BL/6J mice in the present study, it is possible that these observed discrepancies in 20-HETE production may be due to differences in the distribution of these isoforms between various inbred strains. The low level of metabolism of AA by renal microsomes from C57BL/6J mice may indicate the AA is not the preferred substrate for CYP 4A and 4F isoforms in vivo. This hypothesis is supported by previous studies which have demonstrated much higher levels of lauric acid (LA) hydroxylation by renal microsomes as compared to AA hydroxylation in other inbred strains of mice (9, 11, 27) . Also, studies with purified CYP4A14 protein indicate that this isoform is not able to metabolize AA but is able to efficiently metabolize LA (10) . The CYP4A10 isoform shares 92% amino acid homology with the rat CYP4A1 isoform while the 4A12 and 4A14 isoforms share the greatest homology with rat 4A8 and 4A3 isoforms respectively ( Table 2 ). The rat 4A1 isoform has been demonstrated to have the highest 20-HETE generating capability of the rat isoforms even though it is expressed at low levels in the kidney under basal conditions (18) . However, the despite the great degree of homology with the rat CYP4A isoforms, the specific ability of the mouse CYP4A10 and 4A12 isoforms to generate 20-
HETE has yet to be reported.
The mouse provides a powerful tool in which the various physiological actions of 20-HETE in the kidney can be cleanly dissected in vivo. We have identified the isoforms of the CYP4A and CYP4F families throughout the nephron and in renal vessels which may be responsible for the production of 20-HETE in vivo. Several differences in distribution of CYP4A and CYP4F isoforms were identified in specific renal tubular and vascular segments analyzed in male and female C57BL/6J mice. Disparity in the CYP4A and CYP4F isoforms may account for the altered levels of renal 20-HETE production between various inbred strains of mice as well as the difference in 20-HETE production between male and female mice. The specific substrate specificities of each of the murine CYP4A and CYP4F isoforms needs to be determined in order to fully test this hypothesis. These strain difference in renal 20-HETE production need to be taken into account when considering the appropriate genetic background in which to alter the levels of renal 20-HETE production in mice. Strains such as the C57BL/6J exhibit low levels of renal 20-HETE production and would not be an ideal genetic background for models to examine reduced renal 20-HETE production by gene knockout; however, this strain may be appropriate in order to examine the physiological effects of increased renal 20-HETE production via cell-type specific transgenic targeting. These types of transgenic and gene-targeted models will be critical in order to fully determine the complex role of intrarenal 20-HETE production in the regulation of blood pressure and renal function. HETEs is the sum total of 5, 12, and 15-HETE with the major peak being 12-HETE.
Epoxygenase activity is the sum of the formation of 5,6-EET, 11,12-EET and 14,15-EET as well as their corresponding DiHETE metabolites. a is significantly different P <0.05 as compared to corresponding value in male cortex. b is significantly different P <0.05 as compared to corresponding value in female cortex.. 
